Oncolytic bacteria offer several advantages over traditional cancer treatments such as chemotherapy and radiation. These include:
- Selectivity: They can specifically target cancer cells while minimizing damage to normal tissues. - Immune Activation: They can stimulate the immune system to recognize and attack cancer cells more effectively. - Versatility: They can be engineered to carry therapeutic genes, enhancing their anti-tumor activity. - Reduced Side Effects: Due to their selective targeting, the side effects are generally less severe compared to traditional therapies.
